Atlas Trials

Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K)

Clinical trial NCT07510932 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07510932
Sponsor
Korea University Anam Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2026-05-01
Primary completion
2027-03-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.